30 Paul Tudor Jones II Quest Diagnostics Trades
Paul Tudor Jones II's position in Quest Diagnostics is currently worth $885 Thousand. That's 0.01% of their equity portfolio (953rd largest holding). The first Quest Diagnostics trade was made in Q3 2013. Since then Paul Tudor Jones II bought shares 22 more times and sold shares on 21 occasions. The stake costed the investor $778 Thousand, netting the investor a gain of 14% so far.
News about Quest Diagnostics, Inc. and Paul Tudor Jones II
Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum
Circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) can reduce costs by up to 21% across health plan populations when half of eligible p...
Quest Diagnostics: Quest Colleague Is Exhibiting Care for Every Patient in Her Chair
NORTHAMPTON, MA / ACCESSWIRE / March 14, 2024 / Quest Diagnostics: With 7 years at Quest under her belt, Donna Grant-Rudolph, Patient Services Representative...